Accordingly, the ratio between Th17 and CD4 Treg in RA patients was significantly elevated as compared with that in the control group [0.59 (0.24–1.07) vs. 0.20 (0.16–0.31), p < 0.001]. This evidence concerns the gene CD4 and rheumatoid arthritis.